Boston Scientific Corporation's latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 6 Aug 2026Quarterly earnings show how the company performed and help investors track progress over time.
Press releases announce important updates that can affect stock price and investor decisions.
Major cost and job changes signal strategy shifts that impact future profits and employee count.
Share buybacks reduce shares outstanding, potentially increasing earnings per share for remaining shareholders.
Strategic investments in new medical technology help companies grow and create innovative products.
Board elections and governance changes affect how the company makes decisions and operates.
Quarterly earnings show how the company performed and help investors track progress over time.
Stocky reads Boston Scientific Corporation's official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Boston Scientific Corporation's most recent tracked filing was a 10-Q on 3 Aug 2026: Reports second quarter 2026 financial results.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.